Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

Examining the Effect of a Group-Based Stress Management Course on Empowering the Mental Health of Medical Faculty Students and Resident Physicians: A Randomized Controlled Study

NCT07679503 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-01-01
Last updated
2026-07-01

Condition(s) studied

Group-basedSelf-Help Plus (SH+)Psychoeducational InterventionStress Management Course

Investigational drug(s) / intervention(s)

self help plus

self help plus: The course is designed to help individuals cope with challenging life events and manage stress. The core components of the SH+ course include focusing attention (grounding), stepping back from distressing thoughts and emotions, acting in line with one's values, practicing kindness (self-compassion), and making space for difficult emotions.

Study summary

Physicians and medical students have higher rates of depression, anxiety, burnout, and suicide risk than the general population, and this disparity often begins early, even during medical school. Despite substantial distress, help-seeking is frequently limited due to stigma concerns, career fears, and time constraints, which may allow mental health problems to progress unnoticed and become chronic. Preventive interventions during medical education may reduce current distress and help avert more severe disorders later in professional life. Group-based psychoeducation is a cost-effective approach with advantages such as scalability, peer support, and learning benefits without requiring personal disclosure. The WHO Self-Help Plus (SH+) program is an ACT-informed, easily deliverable group stress management course, and randomized controlled trials across settings suggest SH+ can reduce psychological distress and depressive symptoms while improving coping skills and resilience. In Türkiye, evidence on group-based interventions for medical students and resident physicians remains limited and focuses mainly on documenting symptom levels rather than testing interventions; therefore, this study aims to evaluate a group-based stress management course and examine the feasibility and cultural adaptation of SH+-like programs in Turkish medical education.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Being a medical student or a resident physician at Eskişehir Osmangazi University Faculty of Medicine * Being 18 years of age or older Exclusion Criteria: * Individuals with active suicidal ideation * Individuals with severe mental disorders such as psychotic disorders or bipolar disorder * Individuals with alcohol or substance dependence * Students under 18 years of age

Primary outcome measure(s)

  • Depression Anxiety Stress Scales - Short Form (DASS-21) — 1th-30th days
    The DASS-21 is a self-report instrument developed to assess respondents' levels of depression, anxiety, and stress (Lovibond \& Lovibond, 1995).
  • Suicide Probability Scale - SPS — 1 th - 30 th days
    The original form of the scale was developed by Cull and Gill (1982) to measure the likelihood of suicide.

Trial sites (1)

FacilityCityRegionStatus
Eskişehir Osmangazi University Eskişehir Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07679503 on ClinicalTrials.gov ↗ ← All trials in Turkey